Literature DB >> 424097

Prolactin and deficient luteal function.

E del Pozo, H Wyss, G Tollis, J Alcañiz, A Campana, F Naftolin.   

Abstract

The possibility of prolactin-dependent subfertility was investigated in a group of 8 women, with luteal insufficiency exhibiting moderately elevated plasma prolactin (PRL) levels and/or galactorrhea. Another group of 10 normal women volunteers served as the control group. A "luteal index" was elaborated by integration of the area below the curve of plasma progesterone (P) values recorded throughout the postovulatory period. The calculated index for normal women was 177 +/- 35 (SD) expressed as [(ng/ml) x time], and the value of 107 (--2 SD) was adopted as the lower limit of normality (97.5% confidence limit). All 8 patients had luteal indexes (range 20--105) below the established limit. Therapy with bromocriptine (CB 154), 5 mg/day, suppressed PRL to normal levels and prolonged the postovulatory hyperthermic phase in 6 out of 8 women. This was accompanied by an improvement in the luteal index, and 5 women conceived. It is concluded that prolactin may interfere with normal progesterone synthesis by the corpus luteum, as demonstrated by the prompt restoration of fertility by bromocriptine treatment in women with regular cycles and inadequate luteal function.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 424097

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility.

Authors:  Tahereh Orouji Jokar; Lindsay T Fourman; Hang Lee; Katherine Mentzinger; Pouneh K Fazeli
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

2.  Characterization of luteal function by measuring the cumulative concentration of serum progesterone and urine pregnanediol-3 alpha-monoglucuronide.

Authors:  G Aprò; G Falkay; M Sas
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

3.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

4.  Hyperprolactinaemia - a problem in patients from the reproductive period to the menopause.

Authors:  Sylwia Pałubska; Aneta Adamiak-Godlewska; Izabela Winkler; Katarzyna Romanek-Piva; Tomasz Rechberger; Marek Gogacz
Journal:  Prz Menopauzalny       Date:  2017-04-26

Review 5.  Treatment of Prolactinoma.

Authors:  Warrick J Inder; Christina Jang
Journal:  Medicina (Kaunas)       Date:  2022-08-13       Impact factor: 2.948

6.  Correlation of prolactin and thyroid hormone concentration with menstrual patterns in infertile women.

Authors:  Goswami Binita; Patel Suprava; Chatterjee Mainak; B C Koner; Saxena Alpana
Journal:  J Reprod Infertil       Date:  2009-10

7.  Prolactin and aggression in women with fertility problems.

Authors:  J A Barry; E Moran; H S Parekh; T Morewood; M Thomas; P J Hardiman
Journal:  J Obstet Gynaecol       Date:  2014-10       Impact factor: 1.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.